Takeda Pharmaceutical Co Ltd (NYSE:TAK)

Delayed Data
As of Aug 23
 -0.14 / -0.84%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 10 analysts offering 12-month price forecasts for Takeda Pharmaceutical Co Ltd have a median target of 24.47, with a high estimate of 29.12 and a low estimate of 17.48. The median estimate represents a +48.65% increase from the last price of 16.46.

Analyst Recommendations

The current consensus among 11 polled investment analysts is to Buy stock in Takeda Pharmaceutical Co Ltd. This rating has held steady since August, when it was unchanged from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Oct 30

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -246.50%
Growthannually -212.65%


Growthquarterly -2.90%
Growthannually 61.78%
Key to the earnings and sales forecast charts.